RegenLab, a leading manufacturer of regenerative cell therapy devices, has recently signed a long-term lease at Thor Equities Group’s state-of-the-art life sciences property in Jersey City, NJ. The company will occupy 15,792 square feet on the sixth floor and relocate from Brooklyn in Q2 2024 for office and medical device manufacturing.
The eight-story property located at 95 Greene St was originally a manufacturing plant for Colgate Palmolive but has been redeveloped by Thor into a modern facility spanning over 350,000 square feet.
JLL’s team of Dan Spero, Blake Goodman, John Cahill Bob Ryan and Craig Eisenhardt acted as exclusive agents for the lease negotiations between RegenLab and Thor Equities Group. According to Goodman: “We are witnessing significant interest from companies like RegenLab who are looking to move from New York to top-notch properties with easy access to skilled labor.” He added that “95 Greene is an ideal location due its close proximity to both NYC and NJ talent pools with excellent transit options.”
This news was first reported by Connect CRE.
